Arrowstreet Capital, Limited Partnership Merck & Co., Inc. Transaction History
Arrowstreet Capital, Limited Partnership
- $121 Billion
- Q3 2024
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Merck & Co., Inc. stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 6,959,133 shares of MRK stock, worth $678 Million. This represents 0.65% of its overall portfolio holdings.
Number of Shares
6,959,133
Previous 6,207,199
12.11%
Holding current value
$678 Million
Previous $768 Million
2.84%
% of portfolio
0.65%
Previous 0.68%
Shares
29 transactions
Others Institutions Holding MRK
# of Institutions
3,819Shares Held
1.88BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.3 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.2 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.6 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.39 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.76 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $247B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...